NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4)
Target
NDUFS4
Molecular classification
Enzyme, Accessory protein of mitochondrial respiratory chain complex I, Iron-sulfur protein
01
Overview
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4), is a nuclear-encoded accessory subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase). It is a peripheral membrane protein located on the matrix side of the inner mitochondrial membrane and contributes to electron transport from NADH to ubiquinone, facilitating ATP synthesis via oxidative phosphorylation. Although NDUFS4 is not directly involved in catalysis, it is essential for proper assembly and stabilization of complex I and may be regulated by phosphorylation. Mutations cause mitochondrial complex I deficiency, Leigh syndrome, and are associated with a broad spectrum of multi-organ mitochondrial diseases, especially neurological and muscular phenotypes; these disorders are often severe and clinically heterogeneous.
Other names
AQDQCI-18CI-18 kDaCI-AQDQMC1DN1Complex I-18 kDa subunitNADH-ubiquinone oxidoreductase 18 kDa subunitcomplex I 18kDa subunitCI-18 kDa subunitNADH dehydrogenase (ubiquinone) Fe-S protein 418kDa subunit (NADH-coenzyme Q reductase)mitochondrial respiratory chain complex I (18-KD subunit)
02
Mechanism of action
Direct inhibition of complex I (e.g., by rotenone, reducing electron transport and ATP production)
03
Biological functions
Electron transport (from NADH to ubiquinone) in mitochondrial respiratory chainATP production via oxidative phosphorylationRegulation/assembly/stabilization of complex I
04
Disease associations
Mitochondrial complex I deficiencyLeigh syndromeLactic acidosisNeurodegenerative diseases (including some forms of Parkinson disease)Hypertrophic cardiomyopathyLeber hereditary optic neuropathyMyopathyLiver disease
05
Safety considerations
Genetic heterogeneity (variable manifestations/difficulty in genotype–phenotype correlation)Loss-of-function mutations can cause severe multisystem mitochondrial diseases, including lethal neonatal diseaseNo established pharmacological therapies; therapeutic intervention is challenging due to essential role in mitochondrial energy production
06
Interacting drugs
Rotenone (complex I inhibitor)
07
Biomarkers
NDUFS4 mutation or deficiency (biomarker for mitochondrial complex I deficiency and Leigh syndrome)Lactate (elevated in lactic acidosis)Reduced mitochondrial complex I activityMRI/clinical markers for Leigh syndrome
Beyond the preview
Go deeper on NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4).